Photocure ASA

Transaction in Own Shares • Apr 2, 2025

Photocure ASA: Transactions made under share buyback program

Oslo, Norway, 2 April 2025: Reference is made to the stock exchange announcement made by Photocure ASA ("Photocure" or the "Company") on 19 March 2025 of the launch of Photocure's program to repurchase up to 200,000 of its own shares for a total maximum amount of NOK 20 million during the period from 20 March 2025, until no later than the annual general meeting in 2025, pursuant to an agreement with DNB Markets.

For the period from and including 19 March 2025, through 1 April 2025, the Company purchased a total of 200,000 shares at an average price of NOK 57.45 per share, all purchased as ordinary market purchases on Euronext Oslo Børs. The Company has now completed the share buyback program announced on 19 March 2025. Please find below the transaction overview:

Date	Aggregated daily	Weighted average	Total daily transaction
	volume (#shares)	share price per day (NOK)	value (NOK)
31.03.2025	8 997	56.76	510 713
01.04.2025	11 355	56.12	637 315
Previously	179 648	57.57	10 342 644
disclosed
buybacks under
the program
(accumulated)
Accumulated under	200,000	57.45	11 490 672
the program

The issuer's holding of own shares:

Following the completion of the above transactions, Photocure owns a total of 514,148 own shares (including 314,148 shares owned prior to the launch of the buyback program), corresponding to 1.9% of Photocure's share capital.

Appendix:

An overview of all transactions made under the buyback program that have been carried out during the above-mentioned time period is attached to this report and available at www.newsweb.no.

For further information, please contact:

Erik Dahl CFO Photocure ASA Tel: +4745055000 Email: ed@photocure.com

About Photocure ASA

Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com and www.cysview.com. All trademarks mentioned in this release are protected by law and are registered trademarks of Photocure ASA.

All trademarks mentioned in this release are protected by law and are registered trademarks of Photocure ASA.

This information is made public by Photocure ASA pursuant to the EU Market Abuse Regulation and subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.